SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing renewed engagement as investors debate its long-term potential versus its meme coin roots, with active community discussions highlighting the project's ecosystem development and token burn efforts. While some traders are focused on short-term price action and potential squeezes, others remain cautious, contrasting the asset's historical performance with broader market sentiment.

Energy Transfer LP engages in natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities, and gathering systems and delivery of natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition, and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acquisition, and marketing services to crude oil markets. The Investment in Sunoco LP segment refers to the distribution of motor fuels to independent dealers, distributors, and other commercial customers and the distribution of motor fuels to end-user customers at retail sites. The Investment in USAC segment offers compression services to its customers in connection with infrastructure applications including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. The company was founded by Kelcy L. Warren in 1996 and is headquartered in Dallas, TX.

Energy Transfer LP - Unit

Energy Transfer LP Unit

Energy Transfer is trending as investors capitalize on surging demand for natural gas to power AI data centers and hyperscale computing infrastructure. The community is actively discussing the stock's role as a critical energy backbone, with many highlighting its robust dividend distribution and the strategic value of its expansive pipeline network as analysts continue to issue bullish target price updates.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as investors focus on its leadership in the real-world asset (RWA) tokenization sector and potential institutional adoption following progress on the Clarity Act. The community is actively debating the token's long-term value, specifically weighing the impact of potential fee switch proposals against ongoing concerns about supply inflation and governance-focused utility.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca is trending as it navigates a critical phase of pipeline development, highlighted by the strategic prioritization of its oncology and biopharma growth targets. Investors are closely monitoring its robust late-stage trial readouts and recent U.S. investment commitments, which remain central to community discussions surrounding the company's long-term revenue ambitions.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is currently experiencing significant market attention following a high-profile investigative report revealing the company's former Chief Medical Officer was a long-term fugitive. Despite the negative headline volatility, the community remains intensely focused on the underlying NXC-201 clinical data, with many investors viewing the dip as a buying opportunity while emphasizing that the trial's scientific integrity remains unaffected by the leadership scandal.

ProShares Trust II - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

Investors are actively debating the potential for a resolution to the Iran-related supply disruptions, as community sentiment fluctuates between anticipating a crash in crude prices upon a peace deal and concerns over sustained volatility and decay in leveraged inverse ETFs. Traders are closely monitoring diplomatic headlines, with many viewing current elevated oil levels as unsustainable while actively managing positions in SCO to hedge against sudden shifts in geopolitical tensions.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

BONK is trending as the community debates its long-term viability following a major governance exploit that drained the treasury and triggered significant selling pressure. While some investors remain hopeful for a turnaround tied to broader Solana ecosystem performance and potential future bull market cycles, many are expressing frustration over the token's persistent decline.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is facing significant downward pressure and stock volatility, despite maintaining strong commercial growth and blockbuster sales for its flagship CAR-T therapy, Carvykti. The community is actively debating the impact of competitive threats from new combination therapies and potential geopolitical concerns, while many investors argue the stock remains heavily oversold and a prime candidate for a buyout or future rerating given its strong pipeline and path to profitability.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

The Defiance Daily Target 2X Long SMCI ETF is facing extreme volatility, with the community closely tracking its sharp price decline following reports of federal investigations and illegal server exportation. Investors are heavily debating the risks of holding leveraged products in this climate, with many expressing concern over potential further downward pressure and the mechanics of decay.

Deckers Outdoor Corp. engages in the business of designing, marketing, and distributing footwear, apparel, and accessories developed for both everyday casual lifestyle use and high performance activities. It operates through the following segments: UGG Brand, HOKA Brand, Teva Brand, Sanuk Brand, Other Brands, and Direct-to-Consumer. The UGG Brand segment offers a line of premium footwear, apparel, and accessories. The HOKA Brand segment sells footwear and apparel that offers enhanced cushioning and inherent stability with minimal weight, originally designed for ultra-runners. The Teva Brand segment focuses on the sport sandal and modern outdoor lifestyle category, such as sandals, shoes, and boots. The Sanuk Brand segment originated in Southern California surf culture and has emerged into a lifestyle brand with a presence in the relaxed casual shoe and sandal categories. The Other Brands segment includes the Koolaburra by UGG brand. The Direct-to-Consumer segment consists of retail stores and e-commerce websites. The company was founded by Douglas B. Otto in 1973 and is headquartered in Goleta, CA.

Deckers Outdoor Corp.

Deckers Outdoor is drawing attention as investors weigh its robust earnings beat and raised guidance against broader concerns regarding growth moderation and the impact of potential trade tariffs on margins. The community remains divided between long-term bulls highlighting the company's debt-free balance sheet and share buyback programs, and skeptics who are questioning whether HOKAs current trajectory can justify its current valuation amidst increasing competitive intensity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease

MannKind stock rose after the FDA approved Furoscix ReadyFlow, as the company also announced a $50 million private placement financing.read more...

MNKD Stock Rises 8% On Furoscix ReadyFlow Approval And $50M Funding Boost  

Equity

FDA approved MannKind’s Furoscix ReadyFlow on Friday.

MNKD Stock Rises Premarket As FDA Verdict Nears – Retail Optimism Builds 

The FDA is expected to announce its decision on MannKind’s sNDA on July 26, 2026.


What This MannKind Filing Reveals About Three Years of Underperformance

Key PointsThis MannKind insider filing details the disposition of 46,795 shares...

What This MannKind Director Sale Signals With $32.7 Million in Quarterly Royalties Revenue Potentially at Risk

Key PointsThe transactions involved 76,880 shares with a total value of about $313,000, based on a weighted average execution price of $4.07 per share...

What This MannKind Sale Signals With Tyvaso Royalties at $32.7 Million

Key PointsDavid Thomson disposed of 123,000 shares at $4.08 per share, representing a total transaction value of about $500,000...

Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk

Key PointsThis filing reported an insider's total disposition of 65,808 shares for an estimated value of $269,000 based on the July 15, 2026 market close...

Is MannKind a Stock to Sell After Its CEO Let Go of 363,200 Shares?

Key PointsThe disposition involved ~363,000 shares valued at ~$1.5 million as of the July 15, 2026 transaction date...

Jim Cramer Says He Blessed MannKind as a Speculation Only

Jim Cramer Says He Blessed MannKind as a Speculation Only...

S&P 500 Jumps For Ninth Week, Longest Since 2023 With DELL Leading Nasdaq To Record Highs, While Positive US-Iran Ceasefire Bets Aid Dow —  UMG, COIN, MNKD, ASTC, ASTS In Focus

President Donald Trump said he was ready to make a “final determination” on a preliminary agreement to extend the ceasefire.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

FDA approval of the new autoinjector marks a major clinical milestone aimed at revolutionizing diuretic therapy for heart failure.

Investors are expressing frustration over the recent $50 million private placement, viewing it as a missed opportunity for the stock price to run.

Mounting shareholder frustration focuses on the company's long-term commercial performance and repeated calls for leadership changes.

Discussion remains centered on whether commercial execution for the expanding pipeline will finally lead to sustained profitable growth.

Traders are closely watching institutional interest and high short positions, speculating on a potential technical breakout from current levels.

Feed

News

Sentiment

Earnings

Fundamentals

Info

MNKDMannkind Corp

Fundamentals

Latest MNKD News